On Dec. 28, 2023, the Centers for Medicare and Medicaid Services (CMS) released a final rule that updates Clinical Laboratory Improvement Amendments of 1988 (CLIA) fees and clarifies CLIA regulations.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellworks Group, Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced that its computational laboratory ...
LINCOLN, Neb--(BUSINESS WIRE)--Celerion, a leading clinical research organization, proudly announces its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) ...
New regulations under the Clinical Laboratory Improvement Amendments (CLIA) introduced updated proficiency testing (PT) and PT referral rules that are now in effect. Although the regulations became ...
Behind every lab result is a complex system designed to ensure accuracy, speed, and safety. From preventing pre-analytical errors to meeting ISO 15189 standards, quality management is the backbone of ...
ST. PAUL, Minn., Jan. 21, 2026 /PRNewswire/ -- Zepto Life Technology has announced the launch of the FungiFlex® Mold Panel, a plasma-based molecular diagnostic test now available through its ...
Craig Mackinnon, M.D., Ph.D., MSHA, Robert B. Adams Endowed Professor, Division Director, Genomic Diagnostics and Bioinformatics, has been named director of the Clinical Laboratory Improvement ...
Marlborough, Mass.-based Akoya Biosciences was awarded CLIA certification for its Advanced Biopharma Solutions lab, the company said in a Nov. 30 news release. The lab specializes in spatial biology, ...
Acquisition will help Predictive Biosciences launch cancer-management diagnostics. Predictive Biosciences acquired OncoDiagnostic Laboratory (ODL), a private CLIA-certified anatomic pathology and ...
STOCKHOLM, May 8, 2023 /PRNewswire/ -- Devyser is today announcing that the company's clinical testing laboratory in Roswell in Atlanta, Georgia, has received CLIA certification. This certification ...
The acquisition, which is subject to customary closing conditions, is expected to close during the first quarter of 2012. MultiGEN, a privately held molecular diagnostic company located in San Diego, ...
The undertaking of research in human participants often includes development of clinical laboratory test results associated with an individual research participant. Depending in part on the specified ...